Biomea Fusion, Inc. (BMEA) vs Xilio Therapeutics, Inc. (XLO)
- Biomea Fusion, Inc. BMEA 0.87 +3.57%
- Xilio Therapeutics, Inc. XLO 8.77 −2.77%
Biomea Fusion, Inc. and Xilio Therapeutics, Inc. are both Biotechnology companies. Biomea Fusion, Inc. and Xilio Therapeutics, Inc. are of similar size ($60.6M and $59.4M). Biomea Fusion, Inc. has the higher net margin (0.00% vs −34.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Xilio Therapeutics, Inc. leads on 8 and Biomea Fusion, Inc. on 4.
Valuation
Profitability
| Metric | BMEA | XLO | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (48.94%) | 0.00% |
| Net margin | 0.00% | (34.06%) | 0.00% |
| Free cash flow margin | 0.00% | (95.59%) | 0.00% |
| Return on equity | (164.14%) | (55.03%) | (56.36%) |
| Return on assets | (59.14%) | (15.16%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack